​

Funding Round

Series C - Aquinox Pharmaceuticals

Series C - Aquinox Pharmaceuticals

Investment Firm

Overview

Aquinox Pharmaceuticals develops and commercializes small molecule therapeutics for the treatment of cancer and inflammatory diseases.

Announced Date

Apr 03, 2013

Closed on Date

Apr 03, 2013

Funding Type

Series C

Highlights

Location

North America

Social

Investor Lead

Johnson & Johnson Development Corporation

Johnson & Johnson Development Corporation

Johnson & Johnson Development Corporation is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

5

Investor Name
Participant InvestorPfizer Venture Investments
Participant InvestorInbio Ventures
Participant InvestorJohnson & Johnson Development Corporation
Participant InvestorBaker Brothers Advisors LLC
Participant InvestorVentures West

Round Details and Background

Aquinox Pharmaceuticals raised $18000000 on 2013-04-03 in Series C

Aquinox Pharmaceuticals develops and commercializes small molecule therapeutics for the treatment of cancer and inflammatory diseases.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 12, 2011
Venture Round - Aquinox Pharmaceuticals
-4.7M
Sep 21, 2011
Venture Round - Aquinox Pharmaceuticals
-3.5M
Apr 03, 2013
Series C - Aquinox Pharmaceuticals
6-18.0M
Jun 17, 2010
Series B - Aquinox Pharmaceuticals
5-25.0M

Recent Activity

There is no recent news or activity for this profile.